Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Patient Information Leaflet last updated on the eMC: 22/06/2011
PIL VARIVAX

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/02/2010 and displayed until 22/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/02/2009 and displayed until 12/02/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to dosage and administration
Updated on 04/08/2008 and displayed until 16/02/2009
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
Updated on 21/05/2008 and displayed until 04/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/06/2007 and displayed until 21/05/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 20/04/2006 and displayed until 13/06/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   varicella-zoster virus (live)